SCHEMBL30565212

SCHEMBL30565212

Cc1cnc(Nc2ccc(C(=O)Nc3ccc4ncccc4c3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK1 P23458 8/20 0.71
▸ HDAC1 Q13547 6/20 0.71
▸ BRD4 O60885 9/20 0.67
▸ JAK2 O60674 6/20 0.62
▸ JAK3 P52333 5/20 0.58
▸ RET P07949 2/20 0.58
▸ WEE1 P30291 2/20 0.58
▸ FLT3 P36888 2/20 0.58
▸ BRDT Q58F21 2/20 0.58
▸ ALK Q9UM73 2/20 0.58
▸ BUB1B O60566 1/20 0.58
▸ BRD2 P25440 1/20 0.58
▸ BRD3 Q15059 1/20 0.58
▸ TYK2 P29597 3/20 0.57
▸ HDAC3 O15379 2/20 0.57
▸ HDAC4 P56524 2/20 0.57
▸ HDAC7 Q8WUI4 2/20 0.57
▸ HDAC2 Q92769 2/20 0.57
▸ HDAC10 Q969S8 2/20 0.57
▸ HDAC11 Q96DB2 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25380756 1.00 JAK1 (0.71) JAK1HDAC1BRD4JAK2JAK3
SCHEMBL30565200 0.92 JAK1 (0.81) JAK1HDAC1BRD4JAK2JAK3
SCHEMBL25383521 0.92 JAK1 (0.81) JAK1HDAC1BRD4JAK2JAK3
SCHEMBL25382228 0.87 JAK1 (0.75) JAK1HDAC1BRD4JAK2JAK3
SCHEMBL30565235 0.87 JAK1 (0.75) JAK1HDAC1BRD4JAK2JAK3
SCHEMBL31163062 0.87 JAK1 (0.76) JAK1HDAC1BRD4JAK2JAK3
SCHEMBL31163090 0.86 JAK1 (0.72) JAK1HDAC1BRD4JAK2JAK3
SCHEMBL28657345 0.85 BRD4 (0.77) JAK1HDAC1BRD4JAK2JAK3
SCHEMBL31163082 0.85 JAK1 (0.72) JAK1HDAC1BRD4JAK2JAK3
SCHEMBL31163048 0.85 JAK1 (0.72) JAK1HDAC1BRD4JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4673149-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA Trustlife Global Inc. (US) 2026-01-07 — — EP disclosed
EP-4486348-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA Trustlife Global Inc. (US) 2025-01-08 — — EP disclosed
WO-2024179699-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA BASH BIOTECH INC. (US) 2024-09-06 — — WO disclosed
WO-2023166153-A1 NEW COMPOUNDS AND TREATMENT OF RENAL CELL CARCINOMA BASH BIOTECH INC (US) 2023-09-07 — — WO disclosed
Send feedback